Abstract
Objective
To investigate possible causes for previously reported glycemia-independent South Asian–white differences in HbA1c.
Methods
Demographic and laboratory data on non-diabetic patients from primary care were analyzed. Linear regression models measured the association between race/ethnicity and three glycemic measures (HbA1c, fructosamine and fasting plasma glucose), adjusted for a range of hematological, biochemical and demographic factors.
Results
Nine hundred and forty-eight patients consisting of 711 white subjects (407 women) and 237 South Asian subjects (138 women) were studied. Unadjusted bivariate analysis showed that South Asians had higher HbA1c concentrations [41 (5.9 %) vs. 40 (5.8 %) mmol/mol (p = 0.011), coefficient 1.21, 95 % CI 0.27, 2.17 (p = 0.011)] similar fructosamine [228.4 vs. 226.7 mmol/L (p = 0.352), coefficient 3.93, 95 % CI 0.79, 7.08 (p = 0.014)] and fasting plasma glucose [5.1 vs. 5.2 mmol/L (p = 0.154), coefficient −0.09, 95 % CI −0.22, −0.04 (p = 0.156)] concentrations than whites. South Asians also had lower hemoglobin, ferritin and vitamin B12 concentrations than whites. After adjustment for independent variables, South Asian ethnicity was associated with higher HbA1c concentrations [0.89, 95 % CI 0.06–1.72 (p = 0.035)], higher fructosamine levels [3.93, 95 % CI 0.79, 7.08 (p = 0.014)] and lower fasting plasma glucose concentrations [−0.12, 95 % CI −0.26, −0.02 (p = 0.026)] compared to white race.
Conclusions
The increased prevalence of hematological abnormalities in South Asians and their higher adjusted HbA1c and fructosamine but lower fasting glucose levels compared to white subjects suggest that ethnic differences in glycation markers may, in part, be due to a combination of erythrocyte factors and glycemia-independent glycation.
Similar content being viewed by others
References
Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M, Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose) (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378:31–40. doi:10.1016/S0140-6736(11)60679-X
World Health Organization (2011) Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. WHO/NMH/CHP/CPM/11.1. World Health Organization, Geneva
Hwang YC, Ahn HY, Park SW, Park CY (2014) Apolipoprotein B and non-HDL cholesterol are more powerful predictors for incident type 2 diabetes than fasting glucose or glycated hemoglobin in subjects with normal glucose tolerance: a 3.3-year retrospective longitudinal study. Acta Diabetol 51(6):941–946. doi:10.1007/s00592-014-0587-x
Cardoso CRL, Leite NC, Ferreira MT, Salles GF (2014) Prognostic importance of baseline and serial glycated hemoglobin levels in high-risk patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study. Acta Diabetol. doi:10.1007/s00592-014-0592-0
Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, Lachin JM, Montez MG, Brenneman T, Barrett-Connor E, Diabetes Prevention Program Research Group (2007) Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the diabetes prevention program. Diabetes Care 30:2453–2457
Likhari T, Gama R (2009) Glycaemia-independent ethnic differences in HbA(1c) in subjects with impaired glucose tolerance. Diabet Med 26:1068–1069. doi:10.1111/j.1464-5491.2009.02803.x
Likhari T, Gama R (2010) Ethnic differences in glycated haemoglobin between white subjects and those of South Asian origin with normal glucose tolerance. J Clin Pathol 63:278–280. doi:10.1136/jcp.2009.065821
Mostafa SA, Davies MJ, Webb DR, Srinivasan BT, Gray LJ, Khunti K (2012) Independent effect of ethnicity on glycemia in South Asians and White Europeans. Diabetes Care 35:1746–1748. doi:10.2337/dc11-2079
Kilpatrick ES, Dominiczak MH, Small M (1996) The effects of ageing on glycation and the interpretation of glycaemic control in type 2 diabetes. QJM 89:307–312
Stickland MH, Paton RC, Wales JK (1984) Haemoglobin A1c concentrations in men and women with diabetes. Br Med J (Clin Res Ed) 289(6447):733
Gallagher EJ, Bloomgarden ZT, Le Roith D (2009) Review of haemoglobin A1c in the management of diabetes. J Diabetes 1:9–17. doi:10.1111/j.1753-0407.2009.00009.x
Ford ES, Cowie CC, Li C, Handelsman Y, Bloomgarden ZT (2011) Iron-deficiency anemia, non-iron-deficiency anemia and HbA1c among adults in the US. J Diabetes 3:67–73. doi:10.1111/j.1753-0407.2010.00100.x
Gargari BP, Aghamohammadi V, Aliasgharzadeh A (2011) Effect of folic acid supplementation on biochemical indices in overweight and obese men with type 2 diabetes. Diabetes Res Clin Pract 94:33–38. doi:10.1016/j.diabres.2011.07.003
Ng JM, Cooke M, Bhandari S, Atkin SL, Kilpatrick ES (2010) The effect of iron erythropoietin treatment on the A1C of patients with diabetes and chronic kidney disease. Diabetes Care 33:2310–2313. doi:10.2337/dc10-0917
Selvin E, Steffes MW, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL (2011) Racial differences in glycaemic markers: a cross-sectional analysis of community-based data. Ann Intern Med 154:303–309. doi:10.7326/0003-4819-154-5-201103010-00004
Angastiniotis M, Modell B (1998) Global epidemiology of hemoglobin disorders. Ann NY Acad Sci 850:251–269. doi:10.1111/j.1749-6632.1998.tb10482.x
Ambruster DA (1987) Fructosamine: structure, analysis, and clinical usefulness. Clin Chem 33:2153–2163
Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F, Chronic Kidney Disease Epidemiology Collaboration (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247–254
Cohen RM, Franco RS, Khera PK, Smith EP, Lindsell CJ, Ciraolo PJ, Palascak MB, Joiner CH (2008) Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood 112:4284–4291. doi:10.1182/blood-2008-04-154112
Khera PK, Joiner CH, Carruthers A, Lindsell CJ, Smith EP, Franco RS, Holmes YR, Cohen RM (2008) Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to haemoglobin glycation. Diabetes 57:2445–2452. doi:10.2337/db07-1820
Delpierre G, Veiga-da-Cunha M, Vertommen D, Buysschaert M, Van Schaftingen E (2006) Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3 K gene and impacts on haemoglobin glycation at specific sites. Diabetes Metab 32:31–39
Moore A (2005) Changing patterns of childhood mortality in Wolverhampton. Arch Dis Child 90:687–691
Saydah S, Cowie C, Eberhardt MS, De Rekeneire N, Narayan KMV (2007) Race and ethnic difference in glycemic control among adults with diagnosed diabetes in the United States. Ethn Dis 17:529–535
Adams AS, Trinacty CM, Zhang F, Kleinman K, Grant RW, Meigs JB, Soumerai SB, Ross-Degnan D (2008) Medication adherence and racial differences in HbA1c control. Diabetes Care 31:916–921. doi:10.2337/dc07-1924
Herman WH, Dungan KM, Wolffenbuttel BHR, Buse JB, Fahrbach JL, Jiang H, Martin S (2009) Racial and ethnic difference in mean plasma glucose, haemoglobin A1c, and 1,5-anhdroglucitol in over 2000 patients with type 2 diabetes. JCEM 94:1689–1694. doi:10.1210/jc.2008-1940
Acknowledgments
The authors thank the laboratory staff of New Cross Hospital for their assistance with sample analyses.
Conflict of interest
None.
Ethical standard
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.
Human and animal rights disclosure
This article does not contain any studies with human or animal subjects performed by the any of the authors.
Informed consent disclosure
Informed consent was not obtained from all patients as spare serum was analysed anonymously as part of a service evaluation in accordance with ethical standards.
Author information
Authors and Affiliations
Corresponding author
Additional information
Managed by Antonio Secchi.
Rights and permissions
About this article
Cite this article
Shipman, K.E., Jawad, M., Sullivan, K.M. et al. Ethnic/racial determinants of glycemic markers in a UK sample. Acta Diabetol 52, 687–692 (2015). https://doi.org/10.1007/s00592-014-0703-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-014-0703-y